Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Quantitative and Qualitative Differences in Response to Influenza and Pneumococcal Vaccines

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
NIAID-funded investigators develop interactive web applications to share data with peers.

Investigators at the Baylor Institute for Immunology Research in Dallas and the Benaroya Research Institute (BRI) in Seattle have used systems immunology and genome-wide profiling to characterize the immune responses elicited by two popular vaccines. They also developed interactive, web-based figures and data exploration tools to share their findings with the broader scientific community. This NIAID-funded work, described online in the April 18, 2013, issue of Immunity, not only provides new insights into how vaccines confer protective immunity, but also demonstrates the potential of web technologies in disseminating the large amounts of data generated by systems immunology research.

For the full study, please visit

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Researchers Describe New Method for Cell Line Authentication
SNP profiling, an effective method to detect misidentification, contamination, and chromosomal abnormalities in mouse cell lines.
Saturday, October 18, 2014
New TB Diagnostic Proves Effective, Expedient, Study Finds
Early NIH support instrumental to development of new tool.
Monday, September 06, 2010
Human Clinical Trial of NIH-Developed Dengue Vaccine Begins
The vaccine was developed by NIAID scientists and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.
Monday, August 16, 2010
NIH-Funded Study Finds Early Haart During TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB
Findings presented at the XVIII International AIDS Conference will help in optimizing treatment of individuals infected with HIV-TB co-infection.
Friday, July 23, 2010
After 40 Years, NIH-Supported Researchers Identify Possible new Treatment for Severe Vasculitis
Early results also suggest that patients with disease relapses respond better to the new treatment regimen.
Friday, July 16, 2010
NIH-Led Scientists Find Antibodies that Prevent most HIV Strains from Infecting Human Cells
Discovery to advance HIV vaccine design, antibody therapy for other diseases.
Monday, July 12, 2010
NIH Funds 10 International Centers of Excellence for Malaria Research
NIAID announces approx. $14 million in first-year funding to establish 10 new malaria research centers around the world.
Monday, July 12, 2010
Gene Pattern May Identify Kidney Transplant Recipients Who Don't Need Life-Long Anti-Rejection Drugs
Finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy.
Friday, May 28, 2010
NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults
Trial complements current studies in HIV-infected children and pregnant women.
Friday, December 11, 2009
H1N1 Virus May Have Biological Advantage over Seasonal Influenza Viruses
Animal testing showed that levels of the 2009 H1N1 virus rose more quickly than levels of the seasonal virus strains.
Friday, September 04, 2009
NIAID Funds Clinical Trials that Address the Problem of Antimicrobial Resistance
Scientists are addressing the threat of antimicrobial drug resistance by launching two new clinical trials aimed at prolonging the effectiveness of antibacterial drugs.
Thursday, September 03, 2009
Genes Key to Staph Disease Severity, Drug Resistance Found Hitchhiking Together
Scientists have also found the gene for the toxin traveling with a genetic component of Staphylococcus that controls resistance to antibiotics.
Monday, August 03, 2009
NIAID Set to Launch Clinical Trials to Test 2009 H1N1 Influenza Vaccine Candidates
U.S. scientists are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.
Thursday, July 30, 2009
Genomes of Parasitic Flatworms Decoded Information Could Lead to new Treatments for Schistosomiasis
Two international research teams have determined the complete genetic sequences of two species of parasitic flatworms that cause schistosomiasis.
Wednesday, July 22, 2009
Experimental TB Drug Explodes Bacteria from the Inside Out
Research discovers how an experimental drug unleashes its destructive force inside the bacteria that cause tuberculosis.
Monday, December 01, 2008
Scientific News
Breaking Through the Barriers to Lab Innovation
Here we examine the drivers behind the move for greater innovation, the challenges and current trends in laboratory informatics, and the tools that can be used to break these barriers.
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Gene Editing Could Enable Pig-To-Human Organ Transplant
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Adult High Blood Pressure Risk Identifiable in Childhood
Groups of people at risk of having high blood pressure and other related health issues by age 38 can be identified in childhood, new University of Otago research suggests.
Analyzing Protein Structures in Their Native Environment
Enhanced-sensitivity NMR could reveal new clues to how proteins fold.
Supercoiled DNA is Far More Dynamic Than the “Watson-Crick” Double Helix
Researchers have imaged in unprecedented detail the three-dimensional structure of supercoiled DNA, revealing that its shape is much more dynamic than the well-known double helix.
Mini-kidneys Successfully Grown from Stem Cells
Researchers from Murdoch Childrens Research Institute have perfected a method of turning stem cells into mini-kidneys for use in drug screening, disease modelling and cell therapy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos